Peter van de Kerkhof

Author

Also Known As

Kerkhof, Peter Van De, P Van De Kerkhof, P Van de Kerkhof, P van de Kerkhof, P. Van De Kerkhof, P. Van de Kerkhof, P. van Kerkhof, P. van de Kerkhof, Peter Van De Kerkhof, Peter Van De Kerkhof, MD

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center Icahn School of Medicine at Mount Sinai Eli Lilly (United States)Dermatologikum Hamburg

About

Peter van de Kerkhof is an author at Radboud University Nijmegen specializing in medicine, dermatology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.2K
2	Engineering	1	1	159
3	Health Sciences	1	1	54
4	Public Health	1	1	66
5	Social Sciences	1	1	54

Peter van de Kerkhof

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis C.E.M. Griffiths, Bruce Strober, Peter van de Kerkhof, New England Journal of Medicine	2010	845
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials C.E.M. Griffiths, Kristian Reich, Mark Lebwohl, The Lancet Randomised TrialsClinical TrialsClinical DermatologyDermatologyExperimental Dermatology	2015	815
European S3‐Guidelines on the systemic treatment of psoriasis vulgaris Delano Pathirana, AD Ormerod, P. Saïag, Journal of the European Academy of Dermatology and Venereology	2009	695
Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council Bruce Strober, Caitriona Ryan, Peter van de Kerkhof, Journal of the American Academy of Dermatology	2019	226
High prevalence of foot diseases in Europe: results of the Achilles Project Tomasz Burzykowski, Geert Molenberghs, Dietrich Abeck, Mycoses	2003	194
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis Eric L. Simpson, Robert Bissonnette, Lawrence F. Eichenfield, Journal of the American Academy of Dermatology ReliabilityEngineeringAtopic DermatitisReliability TestingDiagnosis	2020	159
Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm<sup>®</sup>- and placebo-controlled trial (BRIDGE) Ulrich Mrowietz, Jacek C. Szepietowski, Robert Loewe, British Journal of Dermatology	2016	137
Supporting adherence and healthy lifestyles in leg ulcer patients: Systematic development of the Lively Legs program for dermatology outpatient clinics Maud Heinen, L. Kay Bartholomew, Michel Wensing, Patient Education and Counseling Family MedicineDisease ManagementPreventive MedicineChronic Disease ManagementHealth Policy	2005	66
Ulcer-related problems and health care needs in patients with venous leg ulceration: A descriptive, cross-sectional study Maud Heinen, Anke Persoon, Peter van de Kerkhof, International Journal of Nursing Studies Venous DiseaseVenous Disease TreatmentHealth Care NeedsLower Extremity WoundGastroenterology	2006	65
Once-Weekly Administration of Etanercept 50 mg Improves Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Kristian Reich, Siegfried Segaert, Peter van de Kerkhof, Dermatology	2009	61

Page 1